Literature DB >> 10958938

Structural and numerical aberrations of chromosome 22 in a case of follicular variant of papillary thyroid carcinoma revealed by conventional and molecular cytogenetics.

B Perissel1, I Coupier, M De Latour, N Cardot, F Penault-Llorca, J Jaffray, M Giollant, Y Fonck, P Malet.   

Abstract

This study reports a case of papillary carcinoma with vesicular components showing multiclonal aberrations of chromosome 22 as revealed by RHG-banding cytogenetics and by fluorescence in situ hybridization (FISH; whole chromosome 22 and BCR-ABL-specific locus probes, multi-FISH). Four clones with chromosome 22 changes as the sole abnormality were seen. The main abnormal clone lacked the whole chromosome 22. A del(22)(q11) was observed in a second group of cells. The third clone had an idic(22). Finally, FISH revealed a fourth abnormal cell population with a der(17)t(?17;22). Some of these chromosome 22 alterations have been described in other solid tumors such as meningiomas and neurinomas, suggesting a common genetic pathway of tumor progression occurring in a multistep process. Chromosome 22 changes do not seem to be involved in pure papillary thyroid tumors and therefore could be related to the maintenance of a follicular-type histological pattern.

Entities:  

Mesh:

Year:  2000        PMID: 10958938     DOI: 10.1016/s0165-4608(00)00228-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

Review 1.  Follicular, papillary, and "hybrid" carcinomas of the thyroid.

Authors:  Patrícia Castro; Elsa Fonseca; João Magalhães; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

2.  Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH.

Authors:  Ludwig Hieber; Reinhard Huber; Verena Bauer; Quirin Schäffner; Herbert Braselmann; Geraldine Thomas; Tatjana Bogdanova; Horst Zitzelsberger
Journal:  J Biomed Biotechnol       Date:  2011-03-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.